TD Cowen Maintains Hold on Hims & Hers Health, Lowers Price Target to $23

Benzinga Newsdesk www.benzinga.com Negative 69.4%

Neg 69.4% Neu 0% Pos 0%

TD Cowen analyst Jonna Kim maintains Hims & Hers Health (NYSE:HIMS) with a Hold and lowers the price target from $25 to $23.